Skip to main content
. 2023 Aug 28;16:3725–3738. doi: 10.2147/JIR.S413581

Table 1.

Clinical Characteristics of Patients with Salivary Gland Origin

Total Non-pSS pSS
Patients (n) 50 25 25
Female (n[%]) 46[92] 21[84] 25[100]
Age (yr) 51.34±14.83 50.00±12.84 52.89±17.07
FS+ (n[%]) 22[44] 1[4] 21[84]
ANA+ (n[%]) 37[74] 12[48] 25[100]
SSA+ (n[%]) 19[38] 0[0] 19[76]
SSB+ (n[%]) 8[16] 0[0] 8[32]
RF+ (n[%]) 19[38] 3[12] 16[64]
Acinar atrophy 26[52] 9[36] 17[68]

Abbreviations: FS+, focus score >1; ANA+, antinuclear antibody positive; SSA, anti-SSA antibodies; SSB, anti-SSB antibodies; RF, rheumatoid factor.